Free Trial
Memorial Day Savings! Save $100 on MarketBeat All Access
Claim Your Discount
Claim MarketBeat All Access Sale Promotion

Lyra Therapeutics (LYRA) Institutional Ownership

Lyra Therapeutics logo
$0.74 +0.09 (+13.62%)
As of 05/19/2026 03:00 PM Eastern

Institutional Ownership Changes (13F Filings) for Lyra Therapeutics (NASDAQ:LYRA)

Current
Institutional Ownership
Percentage
95.62%
Number of
Institutional Buyers
(last 12 months)
5
Total
Institutional Inflows
(last 12 months)
$416.81K
Number of
Institutional Sellers
(last 12 months)
3
Total
Institutional Outflows
(last 12 months)
$122.20M
Get LYRA Insider Trade Alerts

Want to know when executives and insiders are buying or selling Lyra Therapeutics stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily.

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.
Skip Chart & View Institutional Buying and Selling Data

LYRA Institutional Buying and Selling by Quarter

Lyra Therapeutics Major Shareholders & Ownership History

Reporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails
2/18/2026 Artia Global Partners LP8,756$27K0.0%N/A0.495%
2/17/2026 Sabby Management LLC175,158$539K0.8%+37.2%9.896%
2/12/2026 DRW Securities LLC16,812$52K0.0%N/A0.947%
11/17/2025 Citadel Advisors LLC19,484$128K0.0%N/A1.101%
8/15/2025 Perceptive Advisors LLC255,150$2.29M0.2%-98.0%15.558%
8/15/2025 Bank of America Corp DE28,542$256K0.0%+33.7%1.740%
8/8/2025 Geode Capital Management LLC10,986$98K0.0%-98.9%0.687%
6/27/2025 Goldman Sachs Group Inc.370,194$47K0.0%-33.4%27.834%
5/16/2025Goldman Sachs Group Inc.370,194$47K0.0%-33.4%0.559%
2/17/2025Two Sigma Investments LP209,997$43K0.0%-25.7%0.321%
2/17/2025Two Sigma Advisers LP385,500$80K0.0%-16.3%0.589%
2/17/2025BNP Paribas Financial Markets244,920$51K0.0%N/A0.374%
2/14/2025Samsara BioCapital LLC1,965,689$406K0.1%-29.3%3.003%
2/14/2025Northern Trust Corp286,310$59K0.0%+56.2%0.437%
2/13/2025ADAR1 Capital Management LLC533,200$110K0.0%N/A0.815%
2/12/2025Geode Capital Management LLC885,966$183K0.0%+15.3%1.353%
2/12/2025JPMorgan Chase & Co.156,442$32K0.0%+161.8%0.239%
11/15/2024State Street Corp488,720$126K0.0%+88.1%0.747%
8/6/2024Acadian Asset Management LLC985,631$271K0.0%N/A1.617%
7/12/2024Rosalind Advisors Inc.1,034,773$286K0.2%-9.6%1.697%
5/17/2024Ikarian Capital LLC1,056,829$6.57M0.7%-15.7%1.733%
5/10/2024Vanguard Group Inc.1,481,481$9.22M0.0%+38.3%2.430%
4/25/2024Rosalind Advisors Inc.1,144,524$7.12M6.7%-39.4%1.916%
2/15/2024Parkman Healthcare Partners LLC754,885$3.96M0.6%+20.8%1.436%
2/14/2024Vestal Point Capital LP3,000,000$15.72M1.7%N/A5.708%
2/13/2024Armistice Capital LLC1,088,000$5.70M0.1%-29.8%2.070%
2/7/2024Jump Financial LLC16,737$88K0.0%N/A0.032%
1/25/2024Heritage Wealth Management Inc. Texas10,000$52K0.0%N/A0.019%
12/6/2023Citigroup Inc.67,677$265K0.0%N/A0.129%
11/15/2023Armistice Capital LLC1,550,000$6.06M0.1%-61.4%2.949%
11/14/2023Prescott Group Capital Management L.L.C.30,000$117K0.0%N/A0.057%
10/24/2023Bank of New York Mellon Corp18,621$73K0.0%N/A0.038%
8/24/2023Perceptive Advisors LLC12,757,562$52.43M1.5%+39.5%25.747%
8/14/2023Samsara BioCapital LLC2,780,261$11.43M2.0%+56.4%8.733%
8/14/2023Pura Vida Investments LLC1,413,242$5.72M0.8%-29.2%4.439%
8/10/2023Letko Brosseau & Associates Inc.31,900$131K0.0%N/A0.100%
2/15/2023Nantahala Capital Management LLC2,220,830$6.97M0.5%-1.1%6.977%
2/14/2023Pura Vida Investments LLC2,157,298$6.77M0.3%-14.1%6.778%
11/15/2022Pura Vida Investments LLC2,510,302$12.58M0.7%-2.6%7.888%
11/14/2022Boothbay Fund Management LLC34,721$174K0.0%-9.5%0.109%
Read this warning immediately (Ad)

Porter Stansberry, founder of one of the world's largest financial research firms, says he's breaking the biggest story of his 26-year career. A famous historian whose books have sold over 45 million copies in 65 languages is warning of a structural shift so large it has only one historical parallel - 1776. One Stanford economist calls it 'the biggest change ever - bigger than electricity, bigger than the steam engine.' Stansberry outlines the stocks to buy, the stocks to sell, and three money moves to position yourself on the right side of this shift.tc pixel

Read Porter Stansberry's full breakdown and protect your wealth now
11/10/2022Nantahala Capital Management LLC2,245,830$11.25M0.7%-5.2%17.262%
8/16/2022Pura Vida Investments LLC2,576,196$14.56M0.8%+394.9%19.802%
8/16/2022CVI Holdings LLC60,822$344K0.0%N/A0.468%
8/15/2022Nantahala Capital Management LLC2,369,668$13.39M0.7%N/A18.214%
8/12/2022Ensign Peak Advisors Inc56,229$318K0.0%+43.6%0.432%
8/12/2022Ikarian Capital LLC347,338$1.96M0.4%-17.8%2.670%
5/16/2022Clearline Capital LP119,924$482K0.1%+84.9%0.922%
2/14/2022Clearline Capital LP64,862$283K0.0%N/A0.499%
2/14/2022Soleus Capital Management L.P.10,000$44K0.0%-95.4%0.077%


LYRA Institutional Ownership - Frequently Asked Questions

During the previous two years, 18 institutional investors and hedge funds held shares of Lyra Therapeutics. The most heavily invested institutionals were Perceptive Advisors LLC ($2.29M), Sabby Management LLC ($539K), Samsara BioCapital LLC ($406K), Rosalind Advisors Inc. ($286K), Acadian Asset Management LLC ($271K), Bank of America Corp DE ($256K), and Citadel Advisors LLC ($128K).Learn more on Lyra Therapeutics' institutional investors.

95.62% of Lyra Therapeutics' stock is owned by institutional investors. Learn more on LYRA's institutional investor holdings.

Of the 12 institutional investors that purchased Lyra Therapeutics' stock in the last 24 months, the following investors and hedge funds have bought the highest volume of shares: Acadian Asset Management LLC ($985.63K), ADAR1 Capital Management LLC ($533.20K), BNP Paribas Financial Markets ($244.92K), State Street Corp ($228.90K), Geode Capital Management LLC ($117.58K), Northern Trust Corp ($103.03K), and JPMorgan Chase & Co. ($96.68K).

Institutional investors have bought a total of 99,776 shares in the last 24 months. This purchase volume represents approximately $416.81K in transactions.

The following institutional investors have sold Lyra Therapeutics stock in the last 24 months: Perceptive Advisors LLC ($12.50M), Geode Capital Management LLC ($1.01M), and Goldman Sachs Group Inc. ($185.31K).

Institutional investors have sold a total of 13,692,744 shares in the last 24 months. This volume of shares sold represents approximately $122.20M in transactions.



This page (NASDAQ:LYRA) was last updated on 5/20/2026 by MarketBeat.com Staff.
From Our Partners